Cite
Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report
MLA
Ying Han, et al. “Demethylating Agents in Combination with CD7-Targeted CAR-T for the Successful Treatment of a Case with Mixed-Phenotype Acute Leukemia Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.” Frontiers in Immunology, vol. 14, Sept. 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1254010.
APA
Ying Han, Hao Yao, Guang-cui He, Si-han Lai, Yan Deng, Shan Zhang, Ying He, Yi-song Xiong, Alex H. Chang, Yi Su, & Hai Yi. (2023). Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1254010
Chicago
Ying Han, Hao Yao, Guang-cui He, Si-han Lai, Yan Deng, Shan Zhang, Ying He, et al. 2023. “Demethylating Agents in Combination with CD7-Targeted CAR-T for the Successful Treatment of a Case with Mixed-Phenotype Acute Leukemia Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.” Frontiers in Immunology 14 (September). doi:10.3389/fimmu.2023.1254010.